However, these medications, classified as GLP-1 receptor agonists (for Semaglutide) and dual GLP-1/GIP receptor agonists (for Tirzepatide), are now being explored for a variety of other potential health benefits beyond their established uses including: improving cardiovascular health, exerting neuroprotective effects, exhibiting anti-inflammatory properties, ad potentially benefitting conditions such as polycystic ovary syndrome (PCOS) and chronic kidney disease
Your Weight Loss Consultation At the LaVie Institute of Plastic Surgery, we believe in providing personalized care to help you achieve your weight loss goals
A review of 30 randomized controlled trials that included 1,736 people with type 2 diabetes or non-alcoholic fatty liver disease found that treatment with GLP-1 agonists significantly reduced both visceral and liver fat
And while portions worked for me, they may not be enough for someone taller, more active, or who has higher calorie needs and it may not work well for families
However, factors like stress, aging, and toxins can deplete its levels
however, these symptoms are very similar between the different presentations of disease
